Related Experiment Video
Updated: Feb 16, 2026

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
Update on Dendritic Cell-Induced Immunological and Clinical Tolerance
Carolina Obregon1, Rajesh Kumar1, Manuel Antonio Pascual1,2
1Department of Medicine, Transplantation Centre and Transplantation Immunopathology Laboratory, Service of Immunology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Tolerogenic dendritic cells (tolDCs) show promise for treating autoimmune diseases and preventing organ transplant rejection. Further research is needed to optimize tolDC therapies for in vivo use.
Area of Science:
- Immunology
- Cell Biology
- Therapeutics
Background:
- Dendritic cells (DCs) are crucial antigen-presenting cells bridging innate and adaptive immunity.
- DCs play key roles in immune responses, immune tolerance, and maintaining tissue homeostasis.
- Specialized DC subsets are involved in initiating immune responses and regulating immune tolerance.
Purpose of the Study:
- To review the characteristics and classification of human DCs.
- To discuss the role of DCs in immune regulation.
- To explore the potential of tolerogenic DCs (tolDCs) for therapeutic applications in autoimmune diseases and organ transplantation.
Main Methods:
- Review of current literature on dendritic cell subsets and their functions.
- Analysis of in vitro and in vivo manipulation strategies for DCs.
- Focus on the application of tolDCs in preclinical and clinical studies.
Main Results:
- DCs are central to immune regulation and tolerance induction.
- Tolerogenic DCs (tolDCs) are being investigated for therapeutic potential.
- Ongoing clinical trials show promise for tolDC-based therapies.
Conclusions:
- Dendritic cells are key players in immune regulation and tolerance.
- Tolerogenic DCs offer a promising therapeutic avenue for autoimmune diseases and transplant rejection.
- Further research is essential to optimize tolDC-based treatments for in vivo application.
Related Concept Videos
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cell-mediated Immune Responses
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cells of the Adaptive Immune Response
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

